Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3673617 | 1.00 | KMT2A (0.36) | KMT2AESR1HIF1ARECQLSMN1; SMN2 | |
| SCHEMBL3673615 | 1.00 | KMT2A (0.36) | KMT2AESR1HIF1ARECQLSMN1; SMN2 | |
| SCHEMBL3673618 | 1.00 | KMT2A (0.36) | KMT2AESR1HIF1ARECQLSMN1; SMN2 | |
| SCHEMBL3870184 | 1.00 | KMT2A (0.36) | KMT2AESR1HIF1ARECQLSMN1; SMN2 | |
| SCHEMBL3870186 | 1.00 | KMT2A (0.36) | KMT2AESR1HIF1ARECQLSMN1; SMN2 | |
| SCHEMBL3869888 | 0.88 | ALDH1A1 (0.35) | KMT2ASMN1; SMN2ALOX15MEN1ALDH1A1 | |
| SCHEMBL3863799 | 0.88 | ALDH1A1 (0.35) | KMT2ASMN1; SMN2ALOX15MEN1ALDH1A1 | |
| SCHEMBL3869890 | 0.88 | ALDH1A1 (0.35) | KMT2ASMN1; SMN2ALOX15MEN1ALDH1A1 | |
| SCHEMBL3869884 | 0.88 | ALDH1A1 (0.35) | KMT2ASMN1; SMN2ALOX15MEN1ALDH1A1 | |
| SCHEMBL3863797 | 0.88 | ALDH1A1 (0.35) | KMT2ASMN1; SMN2ALOX15MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1845078-B1 | PROCESS FOR PRODUCING LARGE CYCLIC KETONE AND INTERMEDIATE THEREFOR | TAKASAGO PERFUMERY CO LTD (JP) | 2017-06-07 | — | — | EP | disclosed |
| EP-1884509-B1 | OPTICALLY ACTIVE 3-METHYLCYCLOPENTADECANONE AND METHOD FOR PRODUCING INTERMEDIATE THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-7846701-B2 | Method for preparing optically active compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-12-07 | — | — | US | disclosed |
| US-7728177-B2 | Optically active 3-methylcyclopentadecanone and method for producing intermediate thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20090124826-A1 | 2-cyclopentadecen-1-one is subjected to a 1,4-conjugate addition reaction of a methyl group by using a methylated organic metal ( dimethylzinc) in presence of a catalyst (trifluoromethanesulfonic acid, cu salt), an enol anion scavenger(propionic anhydride), a specific optically active phosphoramidite | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-05-14 | — | — | US | disclosed |
| US-7479574-B2 | Method of producing macrocyclic ketone, and intermediate thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-01-20 | — | — | US | disclosed |
| EP-1884509-A1 | OPTICALLY ACTIVE 3-METHYLCYCLOPENTADECANONE AND METHOD FOR PRODUCING INTERMEDIATE THEREOF | Takasago International Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| US-20070292925-A1 | Method for Preparing Optically Active Compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070287870-A1 | Method of Producing Macrocyclic Ketone, and Intermediate Thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
| EP-1845078-A1 | PROCESS FOR PRODUCING LARGE CYCLIC KETONE AND INTERMEDIATE THEREFOR | Takasago International Corporation (JP) | 2007-10-17 | — | — | EP | disclosed |
| EP-1813679-A1 | METHOD FOR PREPARING OPTICALLY ACTIVE COMPOUND | Takasago International Corporation (JP) | 2007-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124826-A1 | 2-cyclopentadecen-1-one is subjected to a 1,4-conjugate addition reaction of a methyl group by using a methylated organic metal ( dimethylzinc) in presence of a catalyst (trifluoromethanesulfonic acid, cu salt), an enol anion scavenger(propionic anhydride), a specific optically active phosphoramidite | CPN1, CAPN1, MCOLN1 | KMT2A 2034/4885ESR1 2671/4885HIF1A 4680/4885 |
| US-20070287870-A1 | Method of Producing Macrocyclic Ketone, and Intermediate Thereof | MSMO1, CYP17A1, DNMT1 | KMT2A 553/4885ESR1 1529/4885HIF1A 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.